Isoniazid and Spiriva drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Isoniazid (isoniazid) and Spiriva (tiotropium bromide monohydrate). Common drug interactions include upper respiratory tract infection among females and bronchitis among males.

The phase IV clinical study analyzes what interactions people have when they take Isoniazid and Spiriva. It is created by eHealthMe based on reports of 79 people who take the same drugs from the FDA, and is updated regularly.

What is Isoniazid?

Isoniazid has active ingredients of isoniazid. It is often used in tuberculosis. eHealthMe is studying from 20,174 Isoniazid users. Check the latest studies of Isoniazid.

What is Spiriva?

Spiriva has active ingredients of tiotropium bromide monohydrate. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 156,666 Spiriva users. Check the latest studies of Spiriva.



On Aug, 13, 2026

79 people who take Isoniazid and Spiriva together, and have interactions are studied.

Isoniazid and Spiriva drug interactions.

What are the common drug interactions of Isoniazid and Spiriva, by gender? *:

female:

  1. Upper respiratory tract infection
  2. Alopecia (absence of hair from areas of the body)
  3. Back pain
  4. Systemic candida (whole body fungal infection)
  5. Diarrhoea
  6. Fatigue (feeling of tiredness)
  7. Headache (pain in head)
  8. Hypertension (high blood pressure)
  9. Insomnia (sleeplessness)
  10. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

male:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Urinary tract infection
  4. Abdominal discomfort
  5. Arthralgia (joint pain)
  6. Cough
  7. Drug ineffective
  8. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  9. Headache (pain in head)
  10. Hypoaesthesia (reduced sense of touch or sensation)

What are the common drug interactions of Isoniazid and Spiriva, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Sinus disorder (disease of sinus)
  2. Sinusitis (inflammation of sinus)

40-49:

  1. Pharyngolaryngeal pain

50-59:

  1. Hypoaesthesia (reduced sense of touch or sensation)
  2. Insomnia (sleeplessness)
  3. Pain
  4. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  5. Adverse event
  6. Arthralgia (joint pain)
  7. Bipolar disorder (mood disorder)
  8. Decreased appetite
  9. Depression
  10. Drug hypersensitivity

60+:

  1. Respiratory failure (inadequate gas exchange by the respiratory system)
  2. Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
  3. Pain in extremity
  4. Back pain
  5. Nausea (feeling of having an urge to vomit)
  6. Systemic candida (whole body fungal infection)
  7. Tremor (trembling or shaking movements in one or more parts of your body)
  8. Alopecia (absence of hair from areas of the body)
  9. Decreased appetite
  10. Diarrhoea

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 30 people, 37.97%
  2. Osteoporosis (bones weak and more likely to break): 12 people, 15.19%
  3. Depression: 11 people, 13.92%
  4. Joint Pain: 10 people, 12.66%
  5. Asthma: 7 people, 8.86%
  6. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 6 people, 7.59%
  7. Multiple Myeloma (cancer of the plasma cells): 6 people, 7.59%
  8. Pain: 5 people, 6.33%
  9. Gastritis (inflammation of stomach): 5 people, 6.33%
  10. Psoriasis (immune-mediated disease that affects the skin): 4 people, 5.06%

* Approximation only. Some reports may have incomplete information.

Do you take Isoniazid and Spiriva?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Isoniazid and Spiriva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Isoniazid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Spiriva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Isoniazid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Spiriva and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on isoniazid and tiotropium bromide monohydrate (the active ingredients of Isoniazid and Spiriva, respectively), and Isoniazid and Spiriva (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: